Insider · CIK 0002051119
Francis Burrows
officer
Files at KURA (Kura Oncology, Inc.). First filing Jan 28, 2025, latest Sep 25, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $485k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KURA: Kura Oncology, Inc.
KURAOct 9, 2026 · close 10.60
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Kura Oncology, Inc. | $225k 20,726 shares | -33% | - | |
| 30Weak | Kura Oncology, Inc. | $11k 1,311 shares | -4% | +53% from low-30% from high | |
| 31Weak | Kura Oncology, Inc. | $232k 23,726 shares | -41% | +78% from low-19% from high | |
| 30Weak | Kura Oncology, Inc. | $17k 2,166 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | KURA Kura Oncology, Inc. | MOption exercise Common Stock | +30,000 | $6.15 | $185k | 63,053 | 17 d ago |
| Sep 24, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -20,726 | $10.83 | $225k | 42,327 | 17 d ago |
| Sep 24, 2026 | KURA Kura Oncology, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | 17 d ago |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -1,311 | $8.46 | $11k | 32,424 | Jan 27, 2026 |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +185,000 | $0.00 | $0 | 185,000 | Jan 6, 2026 |
| Dec 18, 2025 | KURA Kura Oncology, Inc. | MOption exercise Common Stock | +35,000 | $4.80 | $168k | 57,461 | Dec 19, 2025 |
| Dec 18, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -23,726 | $9.78 | $232k | 33,735 | Dec 19, 2025 |
| Dec 18, 2025 | KURA Kura Oncology, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Dec 19, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -846 | $7.87 | $6,660 | 22,025 | Jan 28, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -1,320 | $7.87 | $10k | 20,705 | Jan 28, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +185,000 | $0.00 | $0 | 185,000 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.